Algernon Logo 1.png
Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies
05 juin 2023 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...
Neuronic and Santa Clara University partner to develop next-gen neurotech for photobiomodulation guided by real-time brain activity
11 mai 2023 12h00 HE | Neuronic Devices Operations GmbH
Integrating photobiomodulation with neurofeedback will revolutionize treatment of brain disorders SANTA CLARA, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Neuronic, a multi-national company focused...
Algernon Logo 1.png
Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M
03 avr. 2023 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, April 03, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
21 mars 2023 16h05 HE | Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...
New Logo.jpg
Social Life Network Announces Name Change on OTC Markets to Decentral Life, Inc.
03 févr. 2023 13h11 HE | Decentral Life, Inc
GREENWOOD VILLAGE, CO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Decentral Life, Inc. (OTC: WDLF), a Technology Business Incubator (TBI), previously named Social Life Network, Inc., is pleased to announce...
Social Life Announces Record Growth in 2022, Topping 300% Increase in Annual Sales
06 janv. 2023 11h35 HE | Social Life Network, Inc.
significantly increased its annual sales by 318% year-over-year from 2021 while holding operating expenses in line with 2021 has significantly increased operating income for 2022 LOS ANGELES, CA,...
Aviv-Clinic Logo.png
Aviv Clinics and America’s Mighty Warriors Partner to Provide Life-Changing Treatments to Veterans Suffering from Concussion, Traumatic Brain Injury
11 nov. 2022 09h12 HE | Aviv Clinics
ORLANDO, Fla., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Aviv Clinics, the global leader in the research and treatment of brain conditions, today announces a pledge of $1 million in in-kind treatments to...
Endonovo Therapeutics Releases Comparative Analysis Demonstrating
28 juil. 2022 09h08 HE | Endonovo Therapeutics, Inc.
More Effective SofPulse® Results Compared With Bioelectronics RecoveryRx® Los Angeles, CA, July 28, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today released superior...
Constant Therapy Announces Publication of Study Demonstrating Improved Outcomes for Post-Stroke Patients Using Its Digital Speech, Language, and Cognitive Therapy
20 juil. 2022 10h46 HE | Constant Therapy Health
LEXINGTON, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- Constant Therapy Health, a brain health digital therapeutics company, announced today the publication of a dosage study in the Journal of Medical...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TrueBlue, Inc. Investors to Inquire About Securities Class Action Investigation – TBI
05 juil. 2022 12h43 HE | The Rosen Law Firm PA
NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of TrueBlue,...